Harrow (HROW) Operating Leases (2019 - 2026)
Harrow's (HROW) quarterly Operating Leases came in at $7.7 million in Q1 2026, down 16.6% year-on-year from $9.2 million in Q1 2025, and down 3.02% quarter-over-quarter from $7.9 million in Q4 2025.
Harrow (HROW) Operating Leases (2019 - 2026) Analysis & Trends
Harrow's Operating Leases history runs 8 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 16.6% year-over-year to $7.7 million in Q1 2026; TTM through Mar 2026 was $7.7 million, a 16.6% decrease from a year earlier, with the FY2025 full-year figure at $7.9 million, down 10.09% from the prior year.
- Operating Leases eased to $7.7 million in Q1 2026 per HROW's latest filing, from $7.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $9.5 million in Q3 2024 and bottomed at $6.5 million in Q4 2023.
- The 5-year median for Operating Leases is $7.7 million (2022), against an average of $7.8 million.
- Across the five-year window, Operating Leases soared 64.16% in 2022 and retreated 16.6% in 2026, its largest moves.
- Year by year, Operating Leases stood at $7.3 million in 2022, then retreated by 11.02% to $6.5 million in 2023, then jumped by 34.76% to $8.8 million in 2024, then declined by 10.09% to $7.9 million in 2025, then dropped by 3.02% to $7.7 million in 2026.
- Per Business Quant, the three latest HROW Operating Leases figures stand at $7.7 million (Q1 2026), $7.9 million (Q4 2025), and $9.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.67 Mn |
| Dec 31, 2025 | 7.91 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | 9.19 Mn |
| Dec 31, 2024 | 8.79 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 6.54 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 6.52 Mn |
| Sep 30, 2023 | 7.52 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 7.88 Mn |
| Dec 31, 2022 | 7.33 Mn |
| Sep 30, 2022 | 8.22 Mn |
| Jun 30, 2022 | 7.70 Mn |
| Mar 31, 2022 | 6.82 Mn |
| Dec 31, 2021 | 6.01 Mn |
| Sep 30, 2021 | 5.01 Mn |
| Jun 30, 2021 | 5.18 Mn |